1. Home >
  2. M&A >
  3. Stake Purchase >
  4. United States >
  5. PharmaCyte Biotech Invests In Femasys

Investment Summary

PharmaCyte Biotech Invests In Femasys

On November 15, 2023, PharmaCyte Biotech invested in life science company Femasys

Investment Highlights
  • This is PharmaCyte Biotech’s 1st transaction in the Life Science sector.
  • This is PharmaCyte Biotech’s 1st transaction in the United States.
  • This is PharmaCyte Biotech’s 1st transaction in Georgia.

Investment Summary
Date 2023-11-15
Target Femasys
Sector Life Science
Investor(s) PharmaCyte Biotech
Deal Type Stake Purchase

Target

Femasys

Suwanee, Georgia, United States
Femasys a biomedical company focused on meeting significant unmet needs for women worldwide. Femasys offers a broad portfolio of in-office, accessible solutions, including a lead late-stage product candidate and innovative therapeutic and diagnostic products. Femasys was founded in 2004 and is based in Suwanee, Georgia.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

PharmaCyte Biotech

Las Vegas, Nevada, United States
Category Company
Founded 1996
Sector Life Science
Employees2
Revenue 6M USD (2024)
DESCRIPTION

PharmaCyte Biotech is a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box, for potential development of cellular therapies for cancer, diabetes and malignant ascites. PharmaCyte Biotech was founded in 1996 and is based in Las Vegas, Nevada.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
State: Georgia M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal